Nitazenes: An expert panel discussion

Catch up on Penington Institute's popular webinar on nitazenes, recorded live on 21 August 2024.

Drawing on fresh lessons from overseas, Penington Institute presents this important webinar featuring an expert panel discussing strategies and responses to help prevent nitazene-related harms in Australia.

There is global concern about the rising rates of harm due to nitazenes – a class of potent synthetic opioids that can be 50-500 times stronger than heroin that are appearing as adulterants and contaminants in unregulated drug supplies.

Nitazenes are intensifying both intentional and unintentional drug overdose in Australia and around the globe, and present a new challenge in drug policy, clinical practice and public health.

Join our expert guest panel:

-Tony Duffin, CEO at Ana Liffey Drug Project, Ireland
-Chris Rintoul, Innovation and Harm Reduction Lead at Cranstoun, UK
-Associate Professor Katherine Isoardi, Emergency Physician and Clinical Toxicologist, Princess Alexandra Hospital (Qld) | Medical Director Qld Poisons Info Centre, Australia

This webinar is hosted by Rita Brien, Senior Project Officer (Workforce Development) at Penington Institute.

To learn more, visit: https://www.penington.org.au/nitazene...